

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| HealthX Ventures Fund IIIFiled to raise in 2023, with no closing reported yet. | 2023 | $100M | $0 | 0 |
| Healthcare Innovation Fund | December 2020 | $25M | $10M | 26 |
| HealthX Ventures Fund IIFiled to raise in 2019, with no closing reported yet. | 2019 | $75M | $0 | 0 |
| HealthX Ventures Fund IFiled to raise in 2015, with no closing reported yet. | 2015 | $30M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Mark Bakken | Active | Digital health, Healthcare services, Climate & energy | 27 | 4 |
Classified sectors of HealthX Ventures’s own portfolio companies, based on 16 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Pandemic Innovation | 32 | AGATHOS, AMOpportunities, Amulet, Cancer IQ, CARDIALEN, Carebot Health, Catalyze, DotCom Therapy, ENSODATA, Epharmix, Fifth Eye, FindSpotz, Geno.Me, ImageMoverMD, KeyCare, Kilter, Medsense Health, NarrativeDx, NOVIR, Nurse Disrupted, Peerbridge Health, Prism FM, Ra Medical Systems, Redox, RehabPath, RxLightning, SentiAR, Slot Check, Veda Data Solutions, VedaPointe, Vinyl Health, Wellbe |
| Cultivation Capital Life Sciences | 7 | CARDIALEN, Fifth Eye, ImageMoverMD, NarrativeDx, Ra Medical Systems, SentiAR, VedaPointe |
| LRVHealth | 2 |
| Kristi EbongNot on the current fund | Slowing | None listed | 2 | 1 |
| Shobhan ThakkarNot on the current fund | Quiet | None listed | 0 | 0 |
| William Schmidt | Quiet | Digital health, Medical devices | 7 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of HealthX Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| KeyCare, RxLightning |
| Arboretum Ventures | 1 | Fifth Eye |
| Arthur Ventures | 1 | Catalyze |
| Baird Venture Partners | 1 | Catalyze |
| Battery Ventures | 1 | Redox |
| Lewis & Clark | 1 | Catalyze |
| OCA Ventures | 1 | AMOpportunities |
| Rivervest | 1 | CARDIALEN |
| RRE Ventures | 1 | Redox |
| Silverton Partners | 1 | Prism FM |
| Venture Investors Health | 1 | ENSODATA |
| Wrangler | 1 | Redox |
| Zetta Venture Partners | 1 | ENSODATA |
A shared board seat: a company where filings name a HealthX Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.